Life science industry veterans bring nearly four decades of technology R&D and global sales expertise to pioneering gene synthesis company
“Gen9 is undergoing an exciting time of growth and I am delighted to welcome Chris and Devin to the team. Their experience and leadership will allow us to continue the rapid expansion of our operations and meet the strong global demand for our DNA constructs,” said
Bruce brings more than 25 years of sales and commercial leadership experience to Gen9. He joins the company from Cell Signaling Technology (CST) where he was most recently Sr. Director of Sales. In this role, he was responsible for developing the company’s sales presence in
Leake joins Gen9 from Thermo Fisher Scientific, where he was most recently Global Director of Molecular Biology R&D overseeing research in enzyme development and nucleic acid chemistry and biology. Before that, he worked at Dharmacon, an RNA synthesis company acquired by Thermo Fisher Scientific. Leake has more than 100 issued patents and over 30 publications in peer-reviewed journals. He holds a Ph.D. in molecular biology and biochemistry from the
Gen9 is a privately held gene synthesis and synthetic biology company with a rapidly growing portfolio of products. Currently, Gen9 is manufacturing and shipping double-stranded GeneBits® DNA constructs (up to 1,000 base pairs in length) and GeneBytes® DNA constructs (from 1,000 base pairs to 3,000 base pairs). Also, by the end of 2013, Gen9 will begin selling synthesized DNA constructs as long as 10Kb. All of Gen9’s products are sequence verified and sent in clonal form, either in a vector or as linear DNA.
For more information, please visit www.Gen9Bio.com.
Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. The Gen9 technology allows for the lowest-cost and highest-quality DNA constructs commercially available. Founded by world leaders in synthetic biology, Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels. Gen9 is based in
Gen9, GeneBits, and GeneBytes are trademarks or registered trademarks of
Most Popular Stories
- Hezbollah Chief's Assassination Claimed by Sunni Group
- Allstate Seeks to Invest in Minority Firms
- SpaceX's Satellite Launch Is 'Game-Changer'
- Latin Music Conference Turns 25
- U.S. Growth Stayed Steady During Shutdown, Fed Says
- Newtown Massacre Heard on 911 Recordings
- Climate Change Early Warning System Urged
- Guardian Pressured to Stop NSA Stories: Editor
- New Home Sales Shoot up 25 Percent in October
- Reid Confident Congress to Pass Immigration Bill